Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | GAA | P10253 | 1/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | CA12 | O43570 | 4/20 | 0.41 |
| ▸ | CA1 | P00915 | 4/20 | 0.41 |
| ▸ | CA2 | P00918 | 4/20 | 0.41 |
| ▸ | CA7 | P43166 | 4/20 | 0.41 |
| ▸ | CA9 | Q16790 | 4/20 | 0.41 |
| ▸ | CA14 | Q9ULX7 | 4/20 | 0.41 |
| ▸ | NPC1 | O15118 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.40 |
| ▸ | HCRTR1 | O43613 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | ESR1 | P03372 | 1/20 | 0.39 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4284044 | 0.87 | KMT2A (0.50) | TSHRALDH1A1HSD17B10SMN1; SMN2LMNA | |
| SCHEMBL5178794 | 0.87 | TSHR (0.49) | TSHRALDH1A1HSD17B10SMN1; SMN2LMNA | |
| SCHEMBL1809516 | 0.87 | TSHR (0.49) | TSHRALDH1A1HSD17B10SMN1; SMN2LMNA | |
| SCHEMBL1809860 | 0.86 | TSHR (0.49) | TSHRALDH1A1HSD17B10LMNATDP1 | |
| SCHEMBL4318856 | 0.83 | TSHR (0.47) | TSHRALDH1A1HSD17B10LMNAGAA | |
| SCHEMBL129924 | 0.83 | TSHR (0.60) | TSHRALDH1A1HSD17B10LMNATDP1 | |
| SCHEMBL6195998 | 0.80 | TSHR (0.55) | TSHRALDH1A1HSD17B10SMN1; SMN2LMNA | |
| SCHEMBL971903 | 0.80 | CA12 (0.56) | TSHRALDH1A1HSD17B10CA12CA1 | |
| SCHEMBL4738309 | 0.79 | CYP4F2 (0.51) | TSHRALDH1A1HSD17B10CA12CA1 | |
| SCHEMBL19212264 | 0.79 | TSHR (0.50) | TSHRALDH1A1HSD17B10LMNAGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9318706-B2 | Laminated structure, method for producing same, and electronic element comprising same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2016-04-19 | — | — | US | disclosed |
| US-8895675-B2 | Block copolymer | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2014-11-25 | — | — | US | disclosed |
| US-20110177312-A1 | LAMINATED STRUCTURE, METHOD FOR PRODUCING SAME, AND ELECTRONIC ELEMENT COMPRISING SAME | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2011-07-21 | — | — | US | disclosed |
| EP-2325914-A1 | LAMINATED STRUCTURE, METHOD FOR PRODUCING SAME, AND ELECTRONIC ELEMENT COMPRISING SAME | Sumitomo Chemical Company, Limited (JP) | 2011-05-25 | — | — | EP | disclosed |
| US-20100219399-A1 | BLOCK COPOLYMER | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2010-09-02 | — | — | US | disclosed |
| US-20100176377-A1 | Polymeric compound and polymeric electroluminescence element using the same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2010-07-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110177312-A1 | LAMINATED STRUCTURE, METHOD FOR PRODUCING SAME, AND ELECTRONIC ELEMENT COMPRISING SAME | EPCAM, ITGA1, ITGB1 | TSHR 4526/4885ALDH1A1 618/4885HSD17B10 4227/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.